HemosIL RecombiPlasTin 2G — Class II medical device recall Z-1784-2013
Terminated recall by Instrumentation Laboratory Co., reported 2013-07-31, distributed nationwide. Instrumentation Laboratory is recalling HemosIL RecombiPlasTin 2G (RPT2G), Part No. 0020009580 (8 mL Size) due
| Recall number | Z-1784-2013 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Instrumentation Laboratory Co., Bedford, MA, United States |
| Recall initiated | 2013-04-09 |
| Classified | 2013-07-22 |
| Reported by FDA | 2013-07-31 |
| Terminated | 2015-05-06 |
| Distributed | Nationwide (US) |
| Countries outside the US | AR, AT, AU, BE, BG, BM, BR, CA, CH, CL, CO, CR, CZ, DE, DK, EC, EG, ES, FR, GB, GR, GT, HU, ID, IL, IN, IR, IT, JM, JO, JP, KR, KW, LB, LT, MA, MT, MX, MY, NL, NO, PA, PE, PH, PL, PT, RO, RS, RU, SA, SE, SG, SI, TH, TR, TT, TW, UA, UY, VN, ZA |
| Reason classes | specification failure |
| Model numbers | 0020002950 |
| Expiration dates | 2013-05-31, 2013-09-30, 2013-10-31, 2014-01-31, 2014-02-28, 2014-03-31, 2014-05-31, 2014-07-31, 2014-08-31, 2014-09-30, 2015-01-31 |
Product
HemosIL RecombiPlasTin 2G, Part Number 0020002950 (8 ml size). The product is used for the evaluation of the extrinsic coagulation pathway and the monitoring of Oral Anticoagulant Therapy.
Reason for recall
Instrumentation Laboratory is recalling HemosIL RecombiPlasTin 2G (RPT2G), Part No. 0020009580 (8 mL Size) due to being Out of Specification.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1784-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.